CAGE 7UG21Observed activity · FY2019–FY2022

ASHVATTHA THERAPEUTICS, LLC

REDWOOD CITY, CA

Ultimate parent
ASHVATTHA THERAPEUTICS,
UEI DM55CQJEABE3

ASHVATTHA THERAPEUTICS, LLC is a defense supplier facility identified by CAGE 7UG21 in REDWOOD CITY, CA. The contractor received $2.3M in prime obligations during FY2019–FY2022. No tracked subcontract awards were identified for that period. Observed award classifications include R&d-other Sciences-adv Dev.

Observed prime obligations
$2.3M
Tracked subcontract value
$0

Connected platforms

Percentages show share of all observed prime obligation value.

No mapped platform relationships are shown.

Upstream prime customers

Percentages show share of all tracked subcontract award value received.

No tracked upstream prime customer is shown.

Government customers

Percentages show share of all observed prime obligation value.

Department Of The Army100% of prime

Subcontractors

Percentages show share of tracked subcontract awards issued.

No tracked downstream subcontractor is shown.

Observed capabilities

R&d-other Sciences-adv Dev

Connected NSNs

No observed NSNs are shown.

Largest observed award · base-award description

W81XWH18C0180 · $2.3M

TEMPORARY CORNEAL REPAIR (TCR) PROGRAM, AND WILL SUPPORT FOOD AND DRUG ADMINISTRATION (FDA) CLEARANCE/APPROVAL OF A TEMPORARY, NON-SURGICAL SOLUTION TO CLOSE OPEN GLOBE, FULL THICKNESS CORNEAL WOUNDS. THIS SPECIFIC CONTRACT ACTION IS FOR POTENTIAL DEVELOPERS TO ENGAGE THE FDA, CONDUCT GLP ANIMAL STUDIES, AND DELIVER PROTOTYPE DEVICES TO THE GOVERNMENT.

Ask Mimir about ASHVATTHA THERAPEUTICS, LLC

Open Ask Mimir with this company and CAGE already in context.

Ask a question
Explore the full profile in Mimir

Continue to the wider platform for deeper contracts, suppliers, parts and analysis.

Open platform

Privacy at Mimir

We use first-party product analytics to improve Mimir. You can opt out or choose campaign measurement.